HealthLynked Corp. (HLYK)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
HealthLynked Corp. (HLYK) trades at $3.20 with AI Score 46/100 (Grade C). HealthLynked Corp. operates a cloud-based patient information network, connecting patients and healthcare providers through its digital platform. Market cap: $9.41M, Sector: Healthcare.
Price live · AI analysis from Mar 15, 2026Analyst Coverage for HLYK: HLYK does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates HLYK against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
HLYK: the 1 perspectives are evenly split.
How is this calculated? →HealthLynked Corp. (HLYK) Healthcare & Pipeline Overview
HealthLynked Corp. provides a cloud-based patient information network and healthcare services, including digital health solutions, ACO/MSO services, and medical distribution. The company aims to streamline medical data management and improve patient-provider communication within the fragmented U.S. healthcare landscape, but faces challenges in scaling its integrated platform.
What Is the Investment Thesis for HLYK?
HealthLynked Corp. presents a unique investment opportunity within the digital healthcare space, focusing on patient data management and connectivity. With a market capitalization of $9.41M, the company's growth potential hinges on the expansion of its HealthLynked Network and the increasing adoption of its ACO/MSO services. Key value drivers include the ability to attract and retain physician practices within its network and the successful execution of its medical distribution strategy. The company's high gross margin of 97.8% indicates potential for profitability if it can achieve scale. However, the negative P/E ratio of -2.96 and a negative profit margin of -161.5% highlight significant financial challenges. The company's beta of 2.20 suggests high volatility, reflecting the speculative nature of the stock. Successful expansion of its digital healthcare services and effective cost management are critical for realizing its growth potential.
Based on FMP financials and quantitative analysis
HLYK Key Highlights
- Market capitalization of $9.41M indicates a micro-cap company with high growth potential but also significant risk.
- Gross margin of 97.8% suggests a strong pricing power or efficient cost management in its service offerings.
- Negative P/E ratio of -2.96 reflects current unprofitability, indicating a need for improved operational efficiency or revenue growth.
- Beta of 2.20 indicates high volatility compared to the market, suggesting a speculative investment.
- Operates in four divisions: Health Services, Digital HealthCare, ACO/MSO, and Medical Distribution, providing diversified revenue streams but also operational complexity.
Who Are HLYK's Competitors?
HLYK is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| HWAIF Healwell AI Inc. | $0.53 | -3.52% | $160.75M | 65 |
| ASSF Assisted 4 Living, Inc. | $1.00 | +0.00% | $45.35M | 63 |
| FTRP Field Trip Health Ltd. | $0.84 | +1.07% | $9.81M | 62 |
| SLHGP Skylight Health Group Inc. | $12.00 | -5.88% | 61 | |
| NWKHY Netcare Limited | $7.17 | +0.00% | $843.64M | 50 |
| AONC American Oncology Network, Inc. | $10.00 | +0.00% | $292.48M | 50 |
| DCGO DocGo Inc. | $0.59 | +5.81% | $58.07M | 51 |
| JYNT The Joint Corp. | $9.16 | +2.10% | $130.55M | 51 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are HLYK's Key Strengths?
- Integrated platform offering a range of healthcare services.
- Cloud-based patient information network for efficient data management.
- High gross margin of 97.8% indicating strong pricing power.
- Diverse revenue streams across four divisions.
What Are HLYK's Weaknesses?
- Negative P/E ratio and profit margin indicating current unprofitability.
- Small market capitalization and limited financial resources.
- High beta indicating high volatility and speculative nature.
- Dependence on attracting and retaining physician practices.
What Could Drive HLYK Stock Higher?
- Expansion of the HealthLynked Network to include more patients and providers.
- Growth in ACO/MSO services due to increasing adoption of value-based care.
- Expansion of the medical distribution division to offer a wider range of products.
- Potential strategic partnerships or acquisitions to expand capabilities and market reach.
- Expansion of telehealth services to provide remote consultations and monitoring to patients.
What Are the Key Risks for HLYK?
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Intense competition from larger, more established players in the digital health market.
- Regulatory changes and healthcare reform impacting the ACO/MSO business.
- Cybersecurity risks and data breaches compromising patient data.
- Economic downturn impacting patient spending on healthcare services.
- Limited liquidity due to low trading volume on the OTC market.
What Are the Growth Opportunities for HLYK?
- Expansion of the HealthLynked Network: The company can grow by expanding its HealthLynked Network to include more patients and providers. The global digital health market is projected to reach $660 billion by 2025, providing a significant opportunity for HealthLynked to increase its market share. Timeline: Ongoing, with continuous efforts to onboard new users and integrate with existing healthcare systems.
- Growth in ACO/MSO Services: The increasing adoption of value-based care models and the Medicare Shared Savings Program presents a growth opportunity for HealthLynked's ACO/MSO division. The ACO market is expected to reach $60 billion by 2027. Timeline: Ongoing, with continuous efforts to expand its ACO/MSO services to more physician practices.
- Medical Distribution Division Expansion: The company can expand its medical distribution division by offering a wider range of discounted medical supplies to consumers and medical practices. The global medical supplies market is projected to reach $170 billion by 2028. Timeline: Ongoing, with continuous efforts to expand its product offerings and distribution channels.
- Strategic Partnerships and Acquisitions: HealthLynked can pursue strategic partnerships or acquisitions to expand its capabilities and market reach. This could include partnerships with other digital health companies, healthcare providers, or technology companies. Timeline: Potential, with ongoing evaluation of potential partnership and acquisition opportunities.
- Telehealth Services Expansion: HealthLynked can expand its telehealth services to provide remote consultations and monitoring to patients. The telehealth market is expected to reach $175 billion by 2026, driven by increasing demand for remote healthcare services. Timeline: Ongoing, with continuous efforts to expand its telehealth offerings and integrate them into its HealthLynked Network.
What Opportunities Does HLYK Have?
- Expansion of the HealthLynked Network to increase market share.
- Growth in ACO/MSO services due to increasing adoption of value-based care.
- Expansion of the medical distribution division to offer a wider range of products.
- Strategic partnerships and acquisitions to expand capabilities and market reach.
What Threats Does HLYK Face?
- Intense competition from larger, more established players in the digital health market.
- Regulatory changes and healthcare reform impacting the ACO/MSO business.
- Cybersecurity risks and data breaches compromising patient data.
- Economic downturn impacting patient spending on healthcare services.
What Are HLYK's Competitive Advantages?
- Network effect: The HealthLynked Network becomes more valuable as more patients and providers join the platform.
- Integrated platform: The company offers a comprehensive suite of services, including patient data management, healthcare services, and medical distribution.
- Proprietary technology: The company's cloud-based platform and record archiving system provide a competitive advantage.
What Does HLYK Do?
HealthLynked Corp., incorporated in 2014 and headquartered in Naples, Florida, operates a cloud-based patient information network and record archiving system in the United States. The company's mission is to connect patients and healthcare providers through its digital platform, aiming to streamline medical data management and improve communication. HealthLynked operates through four divisions: Health Services, Digital HealthCare, Accountable Care Organization/Managed Service Organization (ACO/MSO), and Medical Distribution. The Health Services division offers obstetrical and gynecological medical services, functional medicine focusing on neurodegenerative diseases, and physical therapy through Bridging the Gap Physical Therapy. The Digital HealthCare division operates the HealthLynked Network, enabling patients and doctors to manage medical information via a cloud-based system. This segment also provides online scheduling for appointments. The ACO/MSO division assists physician practices in providing care through the Medicare Shared Savings Program and offers consulting services to healthcare providers and ACOs. The Medical Distribution Division functions as a virtual distributor of discounted medical supplies to consumers and medical practices. HealthLynked aims to create a comprehensive healthcare ecosystem, but faces competition from larger, more established players in the digital health and healthcare services markets.
What Products and Services Does HLYK Offer?
- Operates a cloud-based patient information network.
- Provides a record archiving system for medical data.
- Offers obstetrical and gynecological medical services.
- Provides functional medicine focusing on neurodegenerative diseases.
- Offers physical therapy services through Bridging the Gap Physical Therapy.
- Operates an ACO and MSO to assist physician practices in providing care.
- Functions as a virtual distributor of discounted medical supplies.
How Does HLYK Make Money?
- Generates revenue from Health Services division through patient care and medical procedures.
- Earns revenue from Digital HealthCare division through subscriptions and licensing fees for the HealthLynked Network.
- Receives revenue from ACO/MSO division through consulting services and shared savings programs.
- Generates revenue from Medical Distribution division through the sale of discounted medical supplies.
What Industry Does HLYK Operate In?
HealthLynked Corp. operates within the rapidly evolving digital health market, which is experiencing significant growth due to increasing adoption of telehealth, electronic health records, and remote patient monitoring. The industry is characterized by intense competition, with established players like Cerner and Allscripts, as well as numerous startups vying for market share. HealthLynked's focus on patient data management and connectivity positions it within the broader trend of value-based care and personalized medicine. The company's success depends on its ability to differentiate itself through its integrated platform and attract a critical mass of patients and providers.
Who Are HLYK's Key Customers?
- Patients seeking medical care and access to their medical records.
- Physician practices looking to improve patient care and participate in shared savings programs.
- Healthcare providers seeking consulting services for ACO/MSO operations.
- Consumers and medical practices purchasing discounted medical supplies.
Company Profile
HealthLynked Corp. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Naples, US. The company is led by CEO Michael Thomas Dent. HLYK has traded publicly since 2017.
How HealthLynked Corp. Is Valued
HealthLynked Corp. carries a market capitalization of $9.41M, placing it in the micro-cap category. Relative to its peer group, HLYK's quantitative score of 46/100 is below the peer average of 60/100.
ROE 67%Key Financial Metrics
Return on equity for HealthLynked Corp. stands at 67.1%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is -26.8%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.19 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -44.2%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 3/9Financial Health
HealthLynked Corp.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
Net buyingInsider Activity
The most recent 11 insider filings for HealthLynked Corp. break down as 0 sales and 11 purchases. On net that is roughly 10.7M shares acquired (about $599K) — insiders putting money in tends to read as conviction.
HLYK Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in HealthLynked's future, indicating that those closest to the company see potential upside.
- Community sentiment has shifted positively, with many discussions highlighting the company's innovative healthcare solutions and their relevance in today's market.
- Increased engagement on social media platforms reflects growing interest and optimism about HealthLynked's growth trajectory and market position.
- Recent partnerships and collaborations hint at strategic moves that could enhance their service offerings and market reach.
Bear Case
- Concerns about the overall healthcare sector's volatility may lead to cautious sentiment among investors, impacting HealthLynked's stock perception.
- Some community members express skepticism about the scalability of HealthLynked's business model, questioning whether it can sustain long-term growth.
- Recent competitive pressures from larger healthcare technology firms could overshadow HealthLynked's advancements, leading to a bearish outlook.
- Insider selling activity has raised red flags for some investors, suggesting a lack of confidence from certain stakeholders about the company's immediate prospects.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
HLYK Latest News
HLYK Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for HLYK.
Price Targets
Wall Street price target analysis for HLYK.
HLYK MoonshotScore
What does this score mean?
The MoonshotScore rates HLYK's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Michael Thomas Dent
CEO
Michael Thomas Dent serves as the CEO of HealthLynked Corp. His background includes experience in managing and growing healthcare-related businesses. He is responsible for the overall strategic direction and operational execution of the company. His leadership focuses on expanding HealthLynked's digital platform and healthcare service offerings. He oversees the company's four divisions and is involved in key decisions related to partnerships, acquisitions, and product development. He manages a team of approximately 20 employees.
Track Record: Under Michael Thomas Dent's leadership, HealthLynked has focused on expanding its HealthLynked Network and developing its ACO/MSO services. Key milestones include the growth of the company's digital platform and the expansion of its medical distribution division. He has focused on integrating the company's various divisions to create a comprehensive healthcare ecosystem. However, the company's financial performance remains a challenge, with ongoing efforts to achieve profitability.
HLYK OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that HealthLynked Corp. may not meet the minimum financial standards or reporting requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited information available to investors and may be subject to greater risks. Unlike companies listed on the NYSE or NASDAQ, OTC Other companies do not have to adhere to stringent listing standards, resulting in less regulatory oversight and potentially higher information asymmetry.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited liquidity due to low trading volume.
- Lack of regulatory oversight compared to NYSE or NASDAQ-listed companies.
- Potential for information asymmetry due to limited financial reporting.
- Higher risk of fraud or manipulation compared to regulated exchanges.
- Volatility due to speculative trading and limited institutional investment.
- Verify the company's financial statements and reporting frequency.
- Assess the trading volume and bid-ask spread to evaluate liquidity.
- Research the company's management team and their track record.
- Review the company's business model and competitive landscape.
- Consult with a financial advisor to assess the risks and suitability of the investment.
- Check for any regulatory actions or legal issues involving the company.
- Confirm the company's contact information and physical address.
- Operation since 2014 suggests some business viability.
- Presence of four distinct operating divisions indicates diversification.
- Focus on digital healthcare aligns with industry trends.
- CEO with experience in healthcare management.
- Headquarters located in Naples, Florida.
Common Questions About HLYK (Healthcare)
What does HealthLynked Corp. do?
HealthLynked Corp. operates a cloud-based patient information network and record archiving system, connecting patients and healthcare providers. The company's business model revolves around its four divisions: Health Services, Digital HealthCare, ACO/MSO, and Medical Distribution. The Digital HealthCare division, featuring the HealthLynked Network, allows patients and doctors to manage medical information online. The company aims to streamline healthcare data management and enhance patient-provider communication, but faces challenges in scaling its integrated platform and achieving profitability in the competitive healthcare technology market.
What are the main risks for HLYK?
HealthLynked Corp. faces several key risks, including intense competition from larger, more established players in the digital health market. The company's limited financial resources and small market capitalization make it vulnerable to economic downturns and regulatory changes. Cybersecurity risks and data breaches pose a significant threat to patient data and the company's reputation. The company's reliance on attracting and retaining physician practices also presents a risk. Additionally, the low trading volume on the OTC market creates liquidity risk for investors.
What are the key factors to evaluate for HLYK?
HealthLynked Corp. (HLYK) holds an AI score of 46/100 (low). Not financial advice.
How frequently does HLYK data refresh on this page?
HLYK prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven HLYK's recent stock price performance?
HealthLynked Corp. (HLYK) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Integrated platform offering a range of healthcare services. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider HLYK overvalued or undervalued right now?
Valuing HealthLynked Corp. (HLYK) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying HLYK?
Before investing in HealthLynked Corp. (HLYK), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding HLYK to a portfolio?
Key strength of HealthLynked Corp. (HLYK): Integrated platform offering a range of healthcare services. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- The analysis is based on publicly available information and may not reflect all relevant factors.
- AI analysis is pending for HLYK stock.